Bibliografía 1. Giner J, Basualdo LV, Casan P, Hernández C, Macian V, Martínez I, et al. Normativa sobre la utilización de fármacos inhalados. Arch Bronconeumol. 2000; 36(1): 34-43. 2. Devadason SG. Recent advances in aerosol therapy for children with asthma. J Aerosol Med. 2006; 19: 61-6. Cochrane Database Syst Rev 2006; CD001491. 3. Anhoj J, Torzón L, Bisgaard H. Lung deposition of inhaled drugs increases with age. Am J Respir Crit Care Med. 2000; 162(5): 1819-22. 4. Janssens HM, Tiddens HA. Aerosol therapy: the special needs of young children. Pediatr Respir Rev 2006; 7(Suppl I): S83-5. 5. Esposito-Festen J, Ijsselstijn H, Hop W, Van Vliet F, De Jongste, Tiddens H. Aerosol therapy by pressured metered-dose inhaler-spacer in sleeping young children: to do or not to do? Chest. 2006; 130: 487-92. 6. Síndrome de obstrucción bronquial en la infancia. Grupo de Trabajo para el estudio de la enfermedad asmática en el niño. An Esp Pediatr. 2002; 56(Suppl 7): 44-52. 7. Esposito-Festen J, Ates B, Van Vliet F, Hop W, Tiddens H. Aerosol delivery to young children by pMDI-spacer: is facemask design important? Pediatr Allergy Immunol. 2005; 16: 348-53. 8. Amirav I, Newhouse MT. Aerosol therapy with valved holding chambers in young children: importance of the facemask seal. Pediatrics. 2001; 108: 389-94. 9. Cates CJ, Bestall J, Adams N. Holding chambers versus nebulisers for inhaled steroids in chronic asthma. Cochrane Database Syst Rev 2006; CD001491. 10. Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2006; 2: CD000052. 11. Castillo Laita JA, De Benito FJ, Escribano MA et al. Consenso de tratamiento del asma en pediatría. An Pediatr (Barc). 2007; 67: 253-73.
Inhaladores
129